Point-of-care viral load testing to manage HIV viraemia during the rollout of dolutegravir-based ART in South Africa: a randomised feasibility study (POwER).
Jienchi DorwardYukteshwar SookrajhRichard LessellsElliot BuloJessica NaidooKeshani NaidooNicola BodleyMlungisi KhanyileClaudia Jansen Van VuurenPravikrishnen MoodleyNatasha SamsunderLara LewisPaul K DrainGail HaywardChristopher C ButlerNigel GarrettPublished in: Journal of acquired immune deficiency syndromes (1999) (2023)
It was feasible to conduct a trial of point-of-care VL testing to manage viraemia. Point-of-care VL lead to quicker results and fewer clinical visits, but estimates of 24-week VL suppression were similar between arms.